DOP01: The effect of vedolizumab on CD8 T cell repertoire homogeneity and blood-gut trafficking in patients with inflammatory bowel diseaseECCO’23 Copenhagen 2023
DOP03: Unfermented β-fructan fibres can induce gut inflammation and tumorigenesis in select Inflammatory Bowel Disease patients mediated by gut microbiotaECCO’23 Copenhagen 2023
DOP04: Single cell RNA sequencing reveals a potential role for IFNγ in priming circulating monocytes for intestinal inflammatory function in Crohn’s Disease.ECCO’23 Copenhagen 2023
DOP05: Single-cell RNAseq temporal analysis of ulcerative colitis patients undergoing tofacitinib treatment reveals a shift in myeloid cells towards pro-inflammatory phenotypes in refractory patientsECCO’23 Copenhagen 2023
DOP06: Deep characterization of IL-23 pathway in different gut segments and associated plasma biomarkers in inflammatory bowel diseaseECCO’23 Copenhagen 2023
DOP07: Targeting the canonical WNT signalling pathway as a potential novel therapy in Crohn´s associated fibrosisECCO’23 Copenhagen 2023